What is the Effectiveness of Current COVID-19 Vaccines Against SARS-CoV-2 Variants? What to Know About the Need for Third Doses
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.26, sa.3, ss.361-368, 2021 (ESCI, TRDizin)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 26 Sayı: 3
- Basım Tarihi: 2021
- Doi Numarası: 10.5578/flora.20219703
- Dergi Adı: FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.361-368
- Anahtar Kelimeler: SARS-CoV-2, COVID-19, Vaccine, Variant, P.1
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Hacettepe Üniversitesi Adresli: Evet
Özet
SARS-CoV-2 genetic variants from alpha (first detected in the UK) to delta (discovered in India this spring) to lambda (currently Argenti- na, Brazil, Chile, Colombia, Ecuador, and Peru) have been emerging and circulating the world. Also, these variants have raised concerns about the continued effectiveness of COVID-19 vaccines. In this review, influential variants cause countries to review their vaccine strat- egies, create new vaccine programs, and accelerate existing vaccine studies. The effectiveness of currently available COVID-19 vaccines on variants is discussed. It is also intended to shed light on what should be known about the necessity of third doses.